535 Howe Street
Dale Matheson Carr-Hilton Labonte LLC
1140 W Pender St #1500-1700
Financials & Filings
AST Trust Company
1600-1066 W Hastings St
CUSIP Number: 393583
Fiscal Year End: December 31
Providing A Unique Opportunity, With A Competitive Advantage
Greenbank Ventures provides outside capital and outside expertise for cannabis licensees. Our team is at the front of the line when it comes to handling change, and are familiar with state regulations, operations, and legality.
Our aim is to secure relationships with more licensed producers and processors as our range of services expand. By approaching from a supply chain and project management standpoint, our ultimate objective is to develop a vertically integrated “hub and spokes” system. We assist in optimizing the production and processing side of cannabis to ensure a continuous supply of low cost product and high quality production paired with strategic partnerships.
Building A Replicable Model
We have developed a replicable model for state expansion, and know what it takes to scale. By using a multi-state operation strategy, we seek to replicate this model in other states where recreational and/or medical marijuana may be cultivated and sold, as the US moves towards federal legalization. Our proven model for success enables us to simplify the expansion process by minimizing hurdles and optimizing for scale.
Demonstrated Capabilities For Unlimited Potential
The founders of Greenbank Ventures have been active since 2014, establishing strategic relationships in the cannabis industry across the country, with experienced operations in Washington State, one of the first 3 states to legalize recreational marijuana usage. For 8+ years Greenbank has been working to assist and support licensees in the cannabis industry through turn-key services including; negotiating and assistance of real estate lease relationships, overseeing contracts, providing equipment and related lease agreements, identifying and securing work crews, and a wide range of additional business services.
Through the production and processing steps of the supply chain, Greenbank provides business advice and expertise to assist licensees with optimizing their operations management and logistics. Greenbank provides full spectrum testing for each strain to ensure that licensees are supplying the market with the highest quality cannabis products.
Greenbank’s proven track record can help licensees ramp up supply chain operations without letting costs run out of control. This includes consulting people to set up logistics networks, build and negotiate with supplier bases, manage contracts, drive efficiency in warehousing and distribution, and other key skills. In some cases, companies would be well-served by bringing on high-skilled contract (contingent) employees to build out supply chains as other growing companies have done.
Navigate The Regulatory Environment
Regulation and legal matters around packaging, labeling and operating are especially complicated in the American market as cannabis is still illegal at the federal level. Regulatory matters have proved easier in Canada following nationwide legalization, but a facility with a complex regulatory environment is still key in Canada. Greenbank’s consultants possess these skills from the experience within the cannabis industry, pharmaceutical industry and other highly-regulated spaces such as the beverage industry.
Greenbank’s advisors have unique, specific skills for understanding different niches of fresh cannabis products with particular shipment needs including an understanding of cold chain distribution. With experience within and knowledge of the cannabis, food, and pharmaceutical industries Greenabank provides a unique competitive advantage when scaling unique industries.
Greenbank’s skilled consultants include people on the commodity management side who can negotiate the still wildly-fluctuating commodity prices in the industry. Prices in the cannabis market fluctuate significantly more than other agricultural products so it is paramount that licensees work with experienced negotiators that are familiar with the cannabis industry and historical pricing shifts.
The cannabis industry has experienced cycles of supply surpluses and shortages over the last two years, but the COVID-19 pandemic has brought on a new issue for supply shortages. With challenges coming from both overseas as well as North America, it’s a double-edged sword, In the early months of 2020, ports and factories in China were impacted when the country went into a complete lockdown. These disruptions led to a 2-3 month delay for cultivation materials such as grow lights, pots, and other agricultural commodities. It can take up to six months for flower to reach dispensaries from the processing plant, the pandemic added additional months of setbacks as cannabis producers and processors awaited the necessary supplies. Each hour of downtime can cost hundreds of thousands of dollars and without the proper supplies, plants, and the profits they bring.
Not surprisingly, demand for marijuana products increased due to lockdowns as users began panic buying. Cannabis companies saw record-breaking numbers of orders and higher-than-average total purchase price per customer as nationwide cannabis sales increased by 67% in 2020. As lockdowns nudged demand up, new marijuana crops have not boosted supply as supply typically decreases before yearly outdoor harvests become available during the late summer and fall.
The legal cannabis industry has grown at a staggering rate in Washington State and now contributes roughly $2 billion a year to the Pacific Northwest state’s economy, according to a report from Washington State University. Total retail cannabis sales in Washington hit $1 billion in 2018, surpassing $1.1 billion in 2019 and totaled $1.4 billion in 2020 for a 100% increase over 2016 ($691.3 million). Retail marijuana sales alone have grown 605% between 2015 and 2020 and there is still room for substantial growth to be made. According to estimates by Cowen Inc. marijuana is on its way to becoming an $80 billion industry in the United States by 2030.
Marijuana Is An Essential Business
Despite global restrictions and state-mandated stay-at-home orders that bear store closures, many governors and state officials have taken measures to ensure that medical marijuana patients can maintain access to the cannabis they need.
Deemed as an essential service, as it preserves life, health, public safety and basic societal functioning, marijuana dispensaries are exempt from store closures. Dispensaries have been deemed crucial access points that must remain open for recreational users. For dispensaries that faced store closures due to social distancing, additional delivery methods have been put in place to ensure marijuana is still accessible to those who need it.